Teleflex Incorporated splits its revenue into 6 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Vascular at $243.5 million, 43% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 28, 2025
|
Q2 FY2025
Jun 29, 2025
|
Q1 FY2025
Mar 30, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2,255
|
568
|
570
|
548
|
569
|
567
|
443
|
414
|
442
|
| Americas |
—
|
—
|
349
+14.4%
share 61.2%
|
333
+14.8%
share 60.7%
|
-278
-134.8%
share -48.9%
|
556
share 98.1%
|
305
share 68.9%
|
290
share 69.9%
|
800
share 181.0%
|
| Vascular |
—
|
243
share 42.9%
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
| Interventional |
—
|
210
-2.6%
share 37.0%
|
—
|
—
|
—
|
216
share 38.1%
|
—
|
—
|
—
|
| EMEA |
—
|
—
|
146
+62.0%
share 25.5%
|
147
+77.5%
share 26.8%
|
-79
-149.2%
share -13.9%
|
234
share 41.3%
|
90
share 20.3%
|
83
share 19.9%
|
161
share 36.4%
|
| Surgical |
—
|
114
+4.2%
share 20.1%
|
—
|
—
|
—
|
109
share 19.3%
|
—
|
—
|
—
|
| Asia |
—
|
—
|
76
+59.5%
share 13.3%
|
69
+64.5%
share 12.6%
|
-45
-147.6%
share -7.8%
|
123
share 21.7%
|
48
share 10.8%
|
42
share 10.1%
|
94
share 21.2%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TFX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 96943
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.